Search Results 1031-1040 of 17863 for Assay

1. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

   ... assay: Involved FLC level ≥5mg/dl (≥50mg/l) and an abnormal serum free light chain ratio (<0.26 or >1.65); Biopsy proven plasmacytoma (should be measured ...

2. A Study To Evaluate The Effectiveness, Safety, And Tolerability Of BOS-589 In The Treatment Of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

   Patients with a positive HCV antibody at screening may be eligible if confirmatory testing (i.e., Recombinant Immunoblot Assay [RIBA], or HCV RNA viral load) ...

3. Advanced Endocrinology Fellowship (Minnesota) - Residencies and Fellowships - Mayo Clinic College of Medicine & Science

   Clinical Laboratory Medicine (pertaining to thyroid assays as organized by clinical lab medicine consultants); Nuclear medicine (iodine WBS, PET scan ...

4. Diabetes Clinical Trials - Mayo Clinic Research

   ... assay that would detect antibodies to insulin and insulin analogs. Pilot ... The study also aims to test protocols for efficient isolation of plasma-derived EXO ...

5. A Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas - Mayo Clinic

   ... assay for active, GTP-bound Ras. In NIH 3T3 cells, the assay detected overexpressed, constitutively activated K-, N-, and Ha-Ras and insulin-induced ...

6. Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC - Mayo Clinic

   Evidence of ROS1 fusion by a validated assay. 4. Patients with central nervous system (CNS) involvement, including leptomeningeal carcinomatosis, must be ...

7. ETHAN - ET for Male BC - Mayo Clinic

   ER and PR assays are considered positive if there are \> 1% positive tumor nuclei in the samples. * HER2-negative is defined per the current American ...

8. Light Chain Amyloidosis Maintenance Evaluation - Mayo Clinic

   Patients must have monoclonal protein studies (serum free light chain assay, serum immunofixation or serum MASS-FIX) obtained at time of diagnosis before ...

9. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   ... assays and whole blood B-cell depletion assays. In human lymphoma xenograft models, GA101 exhibits superior antitumor activity, resulting in the induction ...

10. Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis - Mayo Clinic

    ... assays in adult subjects with suspected or confirmed diagnosis of noncirrhotic NASH with no fibrosis to moderate fibrosis (stages F0-F2) and correlate PD ...